β¨ Medicines Approval Notices
NEW ZEALAND GAZETTE
No. 80
Dated this 20th day of May 1991.
MAURICE WILLIAMSON, Associate Minister of Health.
go5337
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Tolrestat 200 mg | Capsule | Ayerst Laboratories, Division of Ayerst, McKenna and Harrison Inc., St Laurent, Quebec, Canada | Alredase |
| Etodolac 200 mg | Capsule | Ayerst Laboratories Ltd., Andover, Hampshire, England or Ayerst Laboratories Pty Ltd., Paramatta, NSW, Australia | Lodine |
| Cefotetan 0.5 g, 1 g, 2 g | Powder for reconstitution for injection | Les Laboratoires Principharm, Montreuil, France | Apatef |
| Morphine hydrochloride 1 mg/ml, 2 mg/ml, 5 mg/ml, 10 mg/ml | Solution for injection | Delta West Ltd., Bentley, Western Australia | Morphine Mixture |
| R metHuG-CSF 300 mcg/1 ml, 480 mcg/1.6 ml | Solution for injection | F Hoffman-La Roche Ltd., Basle, Switzerland | Neupogen |
| Diclofenac diethylamine 1.16% | Topical gel | Ciba Geigy Ltd., Basle, Switzerland | Voltaren Emulgel |
| Nafarelin acetate 2 mg/ml | Metered dose nasal spray | Usine Le Petit Paris, Leuville-sur-Orge, Montlhery, France | Synarel |
| Calcipotriol 50 mcg/gm | Ointment | Leo Laboratories Ltd., Dublin, Ireland | Daivonex |
| Famotidine 20 mg, 40 mg | Tablet | Pacific Pharmaceuticals Ltd., Mount Wellington, Auckland | Famox |
| Pindolol 5 mg, 10 mg, 15 mg | Tablet | Novopharm Ltd., Scarborough, Ontario, Canada | Vypen |
| Nonoxynol-9 1 gm | Vaginal sponge | Whitehall Laboratories, Division of American Home Product Corporation, Hammonton, New Jersey, United States of America | Today Sponge |
Dated this 20th day of May 1991.
MAURICE WILLIAMSON, Associate Minister of Health.
go5338
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Purified capsular polysaccharide 25 mcg | Solution for injection | Connaught Laboratories Inc., Swiftwater, Pennsylvania, United States of America | ProHibit |
| Diphtheria toxoid protein 18 mcg | |||
| Thiomersal 50 mcg |
This replaces the consent gazetted 11 April 1991.
Dated this 20th day of May 1991.
MAURICE WILLIAMSON, Associate Minister of Health.
go5548
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1991, No 80
NZLII —
NZ Gazette 1991, No 80
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare20 May 1991
Medicines Act, New Medicines, Pharmaceutical Approvals, Drug Distribution
- MAURICE WILLIAMSON, Associate Minister of Health
π₯ Consent to Distribution of New Medicine (Replacement)
π₯ Health & Social Welfare20 May 1991
Medicines Act, New Medicine, Pharmaceutical Approval, Drug Distribution, Replacement Consent
- MAURICE WILLIAMSON, Associate Minister of Health